Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, d (Q45910955)
scientific article published on June 30, 2012
Language:
Current Data About Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, d
(P31) (Q13442814)
(P248)
(P698) 22748590
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/22748590

(P50) (Q47006499)
(P1545) 2
(P1932) Jürgen K Rockstroh
(P248)
(P698) 22748590
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/22748590

(Q108298727)
(P1545) 4
(P1932) Jean-Michel Molina
(P248)
(P698) 22748590
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/22748590

(Q114417887)
(P1545) 5
(P1932) Joseph Gathe
(P248)
(P698) 22748590
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/22748590

(Q114777924)
(P1545) 9
(P1932) Javier Szwarcberg
(P248)
(P698) 22748590
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/22748590

(Q114777925)
(P1545) 13
(P1932) GS-236-0103 Study Team
(P248)
(P698) 22748590
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/22748590

(P304) 2429-2438
(P248)
(P698) 22748590
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/22748590

(P407) (Q1860)

(P433) 9835
(P248)
(P698) 22748590
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/22748590

(P478) 379
(P248)
(P698) 22748590
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/22748590

(P577) Friday, June 1, 2012
(P248)
(P698) 22748590
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/22748590

(P921) (Q422618)
(P887)

(Q155954)
(P887)

(Q423467)
(P887)

(Q422604)
(P887)

(Q5138908)
(P887)

(P1433) (Q939416)
(P248)
(P698) 22748590
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/22748590

(P1476) "Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, d" (language: en)
(P248)
(P698) 22748590
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/22748590

(P2093) Edwin DeJesus
(P1545) 1
(P248)
(P698) 22748590
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/22748590

Keith Henry
(P1545) 3
(P248)
(P698) 22748590
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/22748590

Srinivasan Ramanathan
(P1545) 6
(P248)
(P698) 22748590
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/22748590

Xuelian Wei
(P1545) 7
(P248)
(P698) 22748590
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/22748590

Kitty Yale
(P1545) 8
(P248)
(P698) 22748590
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/22748590

Kirsten White
(P1545) 10
(P248)
(P698) 22748590
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/22748590

Andrew K Cheng
(P1545) 11
(P248)
(P698) 22748590
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/22748590

Brian P Kearney
(P1545) 12
(P248)
(P698) 22748590
(P813) Sunday, December 17, 2017
(P854) http://europepmc.org/abstract/MED/22748590

(P2860) (Q37773748)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960918-0
(P813) Thursday, January 7, 2021
(P887)

(Q57180178)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960918-0
(P813) Thursday, January 7, 2021
(P887)

(Q43208808)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960918-0
(P813) Thursday, January 7, 2021
(P887)

(Q46123491)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960918-0
(P813) Thursday, January 7, 2021
(P887)

(Q53750673)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960918-0
(P813) Thursday, January 7, 2021
(P887)

(Q43161852)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960918-0
(P813) Thursday, January 7, 2021
(P887)

(Q36518993)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960918-0
(P813) Thursday, January 7, 2021
(P887)

(Q43651001)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960918-0
(P813) Thursday, January 7, 2021
(P887)

(Q46900196)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960918-0
(P813) Thursday, January 7, 2021
(P887)

(Q29614889)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960918-0
(P813) Thursday, January 7, 2021
(P887)

(Q42947493)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960918-0
(P813) Thursday, January 7, 2021
(P887)

(Q28269931)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960918-0
(P813) Thursday, January 7, 2021
(P887)

(Q80176025)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960918-0
(P813) Thursday, January 7, 2021
(P887)

(Q48565770)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960918-0
(P813) Thursday, January 7, 2021
(P887)

(Q44513458)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960918-0
(P813) Thursday, January 7, 2021
(P887)

(Q51547763)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960918-0
(P813) Thursday, January 7, 2021
(P887)

(Q43300648)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960918-0
(P813) Thursday, January 7, 2021
(P887)

(Q43092892)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960918-0
(P813) Thursday, January 7, 2021
(P887)

(Q84656730)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960918-0
(P813) Thursday, January 7, 2021
(P887)

(Q40100382)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960918-0
(P813) Thursday, January 7, 2021
(P887)

(Q80590889)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960918-0
(P813) Thursday, January 7, 2021
(P887)

(Q36628549)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960918-0
(P813) Thursday, January 7, 2021
(P887)

(Q59709783)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960918-0
(P813) Thursday, January 7, 2021
(P887)

(Q33946925)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960918-0
(P813) Thursday, January 7, 2021
(P887)

other details
description scientific article published on June 30, 2012

External Links
(P356) 10.1016/S0140-6736(12)60918-0
(P698) 22748590
(P8608) release_ueahx5nsyjbapky7zmnjl5cpo4